CRITICAL · CVSS 9.8 ACTIVELY EXPLOITED PATCH AVAILABLE

CVE-2026-123218: IBM Aspera Faspex Incorrect Authorization Vulnerability

Facts
VendorIBM
ProductAspera Faspex
CVSS score9.8 · CVSS 3.1 · CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS0.7% (percentile 54)
Actively exploitedYes
Added to CISA KEV9 Nov 2026
CISA federal deadline12 Nov 2026
Weakness (CWE)CWE-863
NVD published7 Nov 2026
NVD last modified10 Nov 2026
NVD statusAnalyzed

Affected versions

ProductAffected versionsFixed in
Ibm Aspera Faspexfrom 5.0.0 before 5.0.19.15.0.19.1

Required action (CISA's text)

Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.

Description (NVD)

IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.

SOURCES

Other IBM flaws

Data from NVD, CISA KEV, FIRST EPSS and vendor advisories. Updated 10 Nov 2026.